Published in Radiat Res on September 01, 1991
Radiation-induced transient cisplatin resistance in murine fibrosarcoma cells associated with elevated metallothionein content. Br J Cancer (1993) 0.83
Transport processes of radiopharmaceuticals and -modulators. Radiat Oncol (2011) 0.78
Detection of the multidrug resistance marker P-glycoprotein by immunohistochemistry in malignant lung tumours. Thorax (1996) 0.77
Summary of information on the effects of ionizing and non-ionizing radiation on cytochrome P450 and other drug metabolizing enzymes and transporters. Curr Drug Metab (2012) 0.77
Higher Level of P-glycoprotein Expression in Human Breast Cancer Cells after Radiation Therapy. Breast Cancer (1995) 0.76
Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma. Br J Cancer (1996) 1.84
Pretherapeutic detection of tumour resistance and the results of tumour chemotherapy. Eur J Cancer (1979) 1.49
Immunohistochemical detection of the multi-drug-resistance marker P-glycoprotein in uterine cervical carcinomas and normal cervical tissue. Am J Obstet Gynecol (1992) 1.43
P-glycoprotein expression in treated and untreated human breast cancer. Br J Cancer (1989) 1.39
Effect of highly active antiretroviral therapy on survival in patients with AIDS-associated pulmonary Kaposi's sarcoma treated with chemotherapy. J Clin Oncol (2001) 1.18
Tissue-factor expression in human non-small-cell lung carcinoma measured by immunohistochemistry: correlation between tissue factor and angiogenesis. Int J Cancer (1998) 1.18
Clinical relevance of predictive tests for cancer chemotherapy. Cancer Treat Rev (1982) 1.16
Prognostic relevance of ploidy, proliferation, and resistance-predictive tests in ovarian carcinoma. Cancer Res (1985) 1.15
Wogonin and related natural flavones are inhibitors of CDK9 that induce apoptosis in cancer cells by transcriptional suppression of Mcl-1. Cell Death Dis (2011) 1.14
Expression of Fas (CD95/APO-1) and Fas ligand in lung cancer, its prognostic and predictive relevance. Int J Cancer (1999) 1.10
Depressive action of serum of partially hepatectomized rats on tumour cells in vitro. Eur J Cancer (1967) 1.08
Tumour induction in the rodent Mastomys natalensis by activation of endogenous papilloma virus genomes. Nature (1984) 1.05
Prognostic impacts of cytogenetic findings in clear cell renal cell carcinoma: gain of 5q31-qter predicts a distinct clinical phenotype with favorable prognosis. Cancer Res (2001) 1.04
DNA distribution in non-small-cell lung carcinomas and its relationship to clinical behavior. Cytometry (1985) 1.04
Glucose-related protein (GRP78) and its relationship to the drug-resistance proteins P170, GST-pi, LRP56 and angiogenesis in non-small cell lung carcinomas. Anticancer Res (2000) 1.02
Microarray expression profiles of angiogenesis-related genes predict tumor cell response to artemisinins. Pharmacogenomics J (2006) 1.00
Prognostic significance of DNA patterns and resistance-predictive tests in non-small cell lung carcinoma. Cancer (1985) 1.00
Immunocytochemical detection of a resistance-associated glycoprotein in tissue culture cells, ascites tumors and human tumor xenografts by Mab 265/F4. Anticancer Res (1988) 1.00
The role of copper in drug-resistant murine and human tumors. Biometals (2008) 0.98
Reciprocal correlation between expression of P-glycoprotein and accumulation of rhodamine 123 in human tumors. Anticancer Res (1990) 0.98
[Selective tumour chemotherapy using oncobiograms (author's transl)]. Dtsch Med Wochenschr (1974) 0.97
Detection of the multidrug resistant phenotype in human tumours by monoclonal antibodies and the streptavidin-biotinylated phycoerythrin complex method. Eur J Cancer Clin Oncol (1989) 0.96
Medicinal chemistry of paclitaxel and its analogues. Curr Med Chem (2009) 0.95
Inhibition of tumor angiogenesis by antibodies, synthetic small molecules and natural products. Curr Med Chem (2011) 0.95
Coexpression of VEGF and bFGF in human epidermoid lung carcinoma is associated with increased vessel density. Anticancer Res (1997) 0.95
Growth of human bronchial carcinomas in nude mice. Br J Cancer (1985) 0.93
[Possibilities and limits of pre-therapeutic neoplasm sensitivity cytostatics tests under short-term conditions]. Schweiz Med Wochenschr (1975) 0.93
Human tumor xenografts as model for drug testing. Cancer Metastasis Rev (1988) 0.93
Detection of murine S180 cells expressing a multidrug resistance phenotype using different in vitro test systems and a monoclonal antibody. Arzneimittelforschung (1987) 0.92
Vascular endothelial growth factor in newly diagnosed and recurrent childhood acute lymphoblastic leukemia as measured by real-time quantitative polymerase chain reaction. Clin Cancer Res (2001) 0.92
[Quick method for sensitivity tests of malignant tumors against antineoplastic agents]. Klin Wochenschr (1970) 0.90
Detection of drug resistance and P-glycoprotein in human renal cell carcinomas. Eur Urol (1990) 0.90
Overexpression of oncoproteins in non-small cell lung carcinomas of smokers. Carcinogenesis (1993) 0.90
Incorporation of 131 iododeoxyuridine into the DNA of tumour-bearing rats after partial synchronization as a tool in scintigraphic tumour localization. Nucl Med (Stuttg) (1974) 0.89
Vascular endothelial growth-factor expression and angiogenesis in nonsmall cell lung carcinomas. Int J Oncol (1995) 0.89
p53 expression in Wilms' tumor: a possible role as prognostic factor. Int J Oncol (2001) 0.89
Oncoprotein (c-myc, c-erbB1, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinomas of the lung. Clinical and biological correlations. Anticancer Res (1992) 0.88
Clinical correlates of in vitro effect of adriamycin on advanced lung carcinoma. Klin Wochenschr (1976) 0.88
Ethnobotanical survey and cytotoxicity testing of plants of South-western Nigeria used to treat cancer, with isolation of cytotoxic constituents from Cajanus cajan Millsp. leaves. J Ethnopharmacol (2010) 0.87
Induced multidrug-resistance in murine sarcoma 180 cells grown in vitro and in vivo and associated changes in expression of multidrug-resistance DNA-sequences and membrane glycoproteins. Anticancer Res (1989) 0.87
Relationship between the expression of caspase-3 and the clinical outcome of patients with non-small cell lung cancer. Anticancer Res (2000) 0.87
Smoking-related increase of O6-methylguanine-DNA methyltransferase expression in human lung carcinomas. Carcinogenesis (1998) 0.87
Trypanosomatid parasites causing neglected diseases. Curr Med Chem (2010) 0.86
Use of tritiated nucleotide incorporation for prediction of sensitivity of tumors to cytostatic agents. Behring Inst Mitt (1984) 0.86
Natural products in structure-assisted design of molecular cancer therapeutics. Curr Pharm Des (2010) 0.85
Concurrent paclitaxel and radiation therapy for breast cancer. Semin Radiat Oncol (1999) 0.85
Messenger RNA expression of resistance proteins and related factors in human ovarian carcinoma cell lines resistant to doxorubicin, taxol and cisplatin. Anticancer Drugs (1997) 0.85
Protein expression profiles indicative for drug resistance of non-small cell lung cancer. Br J Cancer (2002) 0.85
Association of vascular endothelial growth factor expression with tumor cell proliferation in ovarian carcinoma. Anticancer Res (1997) 0.85
[Incorporation of a 131-iodine-deoxycytidine monophosphate protamine complex into the DNA of tumor-bearing rats following partial synchronization with hydroxyurea]. Nucl Med (Stuttg) (1975) 0.84
Isopycnic density-gradient centrifugation: a separation parameter which improves flow cytometric measurements on heterogeneous tumors. Cytometry (1983) 0.84
Sensitivity tests of tumors to cytostatic agents. I. Comparative investigations on transplanted tumors in vivo and in vitro. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol (1975) 0.84
Association of resistance-related protein expression with poor vascularization and low levels of oxygen in human rectal cancer. Int J Cancer (1996) 0.84
O6-methylguanine-DNA methyltransferase activity and sensitivity to cyclophosphamide and cisplatin in human lung tumor xenografts. Int J Cancer (1998) 0.84
Kinetic complexity of nuclear poly(A)-containing RNA in normal and regenerating rat liver. Eur J Biochem (1979) 0.84
Role of glucose-6-phosphate dehydrogenase for oxidative stress and apoptosis. Cell Death Differ (2006) 0.84
Occurrence of a multidrug-resistant phenotype in human lung xenografts. Br J Cancer (1987) 0.83
Induced multidrug resistance in murine leukemia L1210 and associated changes in a surface-membrane glycoprotein. J Cancer Res Clin Oncol (1989) 0.83
Comparative M-FISH and CGH analyses in sensitive and drug-resistant human T-cell acute leukemia cell lines. Cytogenet Genome Res (2002) 0.83
Resistance to doxorubicin in tumor cells in vitro and in vivo after pretreatment with verapamil. Chemotherapy (1991) 0.82
Reversal of doxorubicin-resistance in sarcoma 180 tumor cells by inhibition of different resistance mechanisms. Cancer Lett (1993) 0.82
Sensitivity tests of tumors to cytostatic agents. II. Investigation on human tumors. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol (1975) 0.82
Analysis of cyclin D1 in de novo and relapsed childhood acute lymphoblastic leukemia. Anticancer Res (1999) 0.82
[Individual chemotherapy of solid tumors]. Med Welt (1976) 0.82
Up-regulation of resistance-related proteins in human lung tumors with poor vascularization. Carcinogenesis (1995) 0.81
Lipid rafts play an important role in the vesicular stomatitis virus life cycle. Arch Virol (2009) 0.81
P-glycoprotein and glutathione S-transferase pi in childhood acute lymphoblastic leukaemia. Br J Cancer (1994) 0.80
Deoxycytidine kinase mRNA expression in childhood acute lymphoblastic leukemia. Anticancer Drugs (1997) 0.80
Biological characterization of subgroups of squamous cell lung carcinomas. Clin Cancer Res (1999) 0.80
Reversal of doxorubicin-resistance in solid tumors by clomipramine. In Vivo (1995) 0.80
Detection of drug resistance in human ovarian carcinoma. Arch Gynecol Obstet (1989) 0.80
Expression of several resistance mechanisms in untreated human kidney and lung carcinomas. Anticancer Res (1992) 0.80
[Effect of carcinogenic nitrosamines and nitrosamides on the incroporation of 3H-thymidine, 3H-uridine and 3H-leucine into Tetrahymena, L-cells and liver explants]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1968) 0.80
Different growth rates of lung tumours in man and their xenografts in nude mice. Eur J Cancer (1980) 0.80
Rapid screening of macromolecular synthesis in single cell cultures. Naturwissenschaften (1968) 0.79
nm23-H1 protein expression in newly diagnosed and relapsed childhood acute lymphoblastic leukemia. Anticancer Res (1999) 0.79
The effects of cytostatic drugs on transplanted tumours. An investigation of the correlation between in vivo and in vitro results. Arch Geschwulstforsch (1974) 0.79
Expression of metallothionein in initial and relapsed childhood acute lymphoblastic leukemia. Ann Hematol (1994) 0.79
Growth kinetics of human lung tumours in nude mice. Exp Cell Biol (1981) 0.79
Expression of heat shock proteins, glutathione peroxidase and catalase in childhood acute lymphoblastic leukemia and nephroblastoma. Cancer Lett (1996) 0.79
In-vitro testing of cyclophosphamide on tumors. Naturwissenschaften (1975) 0.79
Reversal of drug resistance in P-glycoprotein-expressing T-cell acute lymphoblastic CEM leukemia cells by copper N-(2-hydroxy acetophenone) glycinate and oxalyl bis (N-phenyl) hydroxamic acid. Cancer Lett (2006) 0.79
[Sensitivity tests of human malignant tumors to cytostatic drugs]. Klin Wochenschr (1971) 0.79
Microvessel density and vascular endothelial growth factor expression in human tumors of different localization. Oncol Rep (1996) 0.79
Maintenance of morphology and tumour marker production in human epidermoid lung carcinoma xenografts. In Vivo (1992) 0.79
[Sensitivity testing of malignant human tumors against cytostatic agents. II]. Klin Wochenschr (1972) 0.78
Acquired drug resistance in human lung carcinoma xenografts. Arzneimittelforschung (1989) 0.78
Expression of resistance-related proteins in tumoral and peritumoral tissues of patients with lung cancer. Cancer Lett (1996) 0.78
Albumin messenger RNA after partial hepatectomy and sham operation. Biochim Biophys Acta (1980) 0.78
Taxanes in adjuvant and neoadjuvant therapies for breast cancer. Oncology (Williston Park) (1998) 0.78
Changes in the concentrations of elements in liver after partial hepatectomy. Experientia (1974) 0.78
Messenger RNA expression of resistance factors and their correlation to the proliferative activity in childhood acute lymphoblastic leukemia. Cancer Lett (1995) 0.78
MDR1 single nucleotide polymorphism C3435T in normal colorectal tissue and colorectal carcinomas detected by MALDI-TOF mass spectrometry. Anticancer Res (2003) 0.78
Apoptotic index, Fas and bcl-2 in initial and relapsed childhood acute lymphoblastic leukaemia. Apoptosis (1997) 0.78
Green tea catechins (EGCG and EGC) have modulating effects on the activity of doxorubicin in drug-resistant cell lines. Anticancer Drugs (1997) 0.78